| Literature DB >> 26791950 |
Eric Vallabh Minikel1, Sonia M Vallabh2, Monkol Lek3, Karol Estrada3, Kaitlin E Samocha4, J Fah Sathirapongsasuti5, Cory Y McLean5, Joyce Y Tung5, Linda P C Yu5, Pierluigi Gambetti6, Janis Blevins6, Shulin Zhang7, Yvonne Cohen6, Wei Chen6, Masahito Yamada8, Tsuyoshi Hamaguchi8, Nobuo Sanjo9, Hidehiro Mizusawa10, Yosikazu Nakamura11, Tetsuyuki Kitamoto12, Steven J Collins13, Alison Boyd13, Robert G Will14, Richard Knight14, Claudia Ponto15, Inga Zerr15, Theo F J Kraus16, Sabina Eigenbrod16, Armin Giese16, Miguel Calero17, Jesús de Pedro-Cuesta17, Stéphane Haïk18, Jean-Louis Laplanche19, Elodie Bouaziz-Amar19, Jean-Philippe Brandel18, Sabina Capellari20, Piero Parchi20, Anna Poleggi21, Anna Ladogana21, Anne H O'Donnell-Luria22, Konrad J Karczewski3, Jamie L Marshall3, Michael Boehnke23, Markku Laakso24, Karen L Mohlke25, Anna Kähler26, Kimberly Chambert27, Steven McCarroll27, Patrick F Sullivan28, Christina M Hultman26, Shaun M Purcell29, Pamela Sklar29, Sven J van der Lee30, Annemieke Rozemuller31, Casper Jansen31, Albert Hofman30, Robert Kraaij32, Jeroen G J van Rooij32, M Arfan Ikram30, André G Uitterlinden33, Cornelia M van Duijn30, Mark J Daly3, Daniel G MacArthur34.
Abstract
More than 100,000 genetic variants are reported to cause Mendelian disease in humans, but the penetrance-the probability that a carrier of the purported disease-causing genotype will indeed develop the disease-is generally unknown. We assess the impact of variants in the prion protein gene (PRNP) on the risk of prion disease by analyzing 16,025 prion disease cases, 60,706 population control exomes, and 531,575 individuals genotyped by 23andMe Inc. We show that missense variants in PRNP previously reported to be pathogenic are at least 30 times more common in the population than expected on the basis of genetic prion disease prevalence. Although some of this excess can be attributed to benign variants falsely assigned as pathogenic, other variants have genuine effects on disease susceptibility but confer lifetime risks ranging from <0.1 to ~100%. We also show that truncating variants in PRNP have position-dependent effects, with true loss-of-function alleles found in healthy older individuals, a finding that supports the safety of therapeutic suppression of prion protein expression.Entities:
Mesh:
Substances:
Year: 2016 PMID: 26791950 PMCID: PMC4774245 DOI: 10.1126/scitranslmed.aad5169
Source DB: PubMed Journal: Sci Transl Med ISSN: 1946-6234 Impact factor: 17.956